To investigate if canonical Wnt pathway inhibition affects PLX4720 resistant glioma cell viability, we suppressed Wnt signaling by treating RGC with Wnt inhibitor FH535, and also by knocking down RCG beta-catenin via siRNA transfection (Supplementary Figure S7). This evidence concerns the gene CTNNB1 and glioma.